TT
Why was this study not done 10 years ago like you suggest? Why was there no RCT study if it’s the so called gold standard for public reimbursement? Is there any explanation provided?
- Forums
- ASX - By Stock
- Ann: First patient treated in the UK for the TRIPP-FXX study
OSL
oncosil medical ltd
Add to My Watchlist
0.86%
!
$1.16

TTWhy was this study not done 10 years ago like you suggest? Why...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M |
Open | High | Low | Value | Volume |
$1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2150 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 7380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8695 | 1.150 |
2 | 10757 | 1.140 |
1 | 5000 | 1.135 |
1 | 2000 | 1.130 |
2 | 5700 | 1.115 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 7380 | 1 |
1.180 | 5000 | 1 |
1.190 | 25000 | 1 |
1.205 | 1563 | 1 |
1.210 | 5000 | 2 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online